Sylvie Raver leads the brain health and disease portfolio for the Milken Institute’s Science Philanthropy Accelerator for Research and Collaboration (SPARC). Dr. Raver applies her expertise in neuroscience, neurodegenerative disease, mental health, and biomedical research to identify opportunities for philanthropic investments that can have a transformative impact on medical research and health. She guides philanthropists, families, and foundations and implements strategies to deploy philanthropic capital to advance research and health priorities. Dr. Raver has published work on biomedical strategy, focusing on mental health, neurotechnology, and rare neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). She was also instrumental in developing a consensus definition for misophonia, a disorder of decreased tolerance to specific sounds or associated stimuli. Before joining the Milken Institute, Sylvie worked for the Society for Neuroscience, leading the society's global programming and policy efforts around neuroscience training and workforce development. Dr. Raver received her bachelor’s degree from Lafayette College, a doctorate from the University of Maryland School of Medicine, and conducted postdoctoral training at the National Institute on Aging.